Skip to main content

Table 2 Patient characteristics

From: HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia

PatientAge
(years)
SexWPSS risk groupBlood cellsPrimitive cells
(%)
Auer rodNo. of monocytes
Patient 361MaleHighDecrease18Positive0.8 × 109/L
Patient 765MaleVery highDecrease13Positive0.7 × 109/L
Patient 163MaleVery highDecrease15Positive0.4×109/L